Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers.
about
Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data.Full-Length Enrich c-DNA Libraries-Clear Cell-Renal Cell CarcinomaImproving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein.TRIM8 anti-proliferative action against chemo-resistant renal cell carcinoma.Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients.Prognostic significance of preoperative C-reactive protein elevation and thrombocytosis in patients with non-metastatic renal cell carcinoma.MicroRNA-1826 directly targets beta-catenin (CTNNB1) and MEK1 (MAP2K1) in VHL-inactivated renal cancer.CD44 is associated with tumor recurrence and is an independent poor prognostic factor for patients with localized clear cell renal cell carcinoma after nephrectomy.Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients.High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patientsB7-H4 expression is elevated in human U251 glioma stem-like cells and is inducible in monocytes cultured with U251 stem-like cell conditioned medium.MicroRNA expression signatures of stage, grade, and progression in clear cell RCC.B7-H4's role "beyond the tumor".Upregulation of centromere protein H is associated with progression of renal cell carcinoma.Improving outcomes in high-risk, nonmetastatic renal cancer: new data and ongoing trials.Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics.Renal masses--to treat or not to treat? If that is the question are contemporary biomarkers the answer?Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma.Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.Prognostic Significance of Macroscopic Appearance in Clear Cell Renal Cell Carcinoma and Its Metastasis-Predicting Model.The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitors.D9S168 microsatellite alteration predicts a poor prognosis in patients with clear cell renal cell carcinoma and correlates with the down-regulation of protein tyrosine phosphatase receptor delta.Overexpression of ATP citrate lyase in renal cell carcinoma tissues and its effect on the human renal carcinoma cells in vitro.B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer.
P2860
Q31163345-82CB7826-0DE1-4F7B-9442-F185AB26F48FQ34250998-C720FBB1-C49F-48D6-94AC-EC9593FC3AB3Q34363552-726E692F-4D01-47BC-808F-2C90CF6561E9Q34365715-56A6A733-DED6-43BA-BC96-A869D7432DD0Q34408625-E9F63688-5B06-4818-B33F-F74689C76C29Q34609822-9B8C3D0D-E1A8-4EF6-A7B8-23CF97857DB1Q35795361-E2D7D379-A693-4157-88F4-C9E6F0075CF8Q36224896-831A847D-5A69-47D7-83CB-C9CECB3D09C0Q36663605-C1BD5690-6C55-4090-93D2-443D72583093Q37185806-5579A525-406E-4ECB-BEAE-B31D6A5A0F2CQ37409770-D9549240-5FFD-4508-93C3-4006A111B152Q37683051-08B5EA04-BA31-4476-B427-063EBD652F31Q38100700-ADEC06D4-39B3-4774-8FCB-6EBD47529EF9Q38385057-0266CE25-5018-41BE-8A47-0DA10A4F3300Q38648762-944832A0-AE47-4696-9264-81013682F9EDQ42140873-E830E1BD-6EB1-4858-8D11-0217FC4453A1Q42861491-25608C48-2431-4572-B89A-464BA03FACD6Q46650092-F0A7A200-56A2-4ACA-B356-096ED6A98D2BQ47299042-49E22D13-1858-405C-8FC9-AA08B8F114BAQ48528146-97C359A4-869B-4B5A-8A09-E81E084E5870Q52747019-CCD09922-89C5-41BF-BCF8-5F69B06F8C7AQ52939973-F30E21D4-BF60-4E94-9366-0D0D7BC16E09Q54323035-C79BD906-AF02-4BE6-8368-B4E5A883DE2BQ55347723-45383DCA-8C58-4B7E-9BBC-D132FE3F31DDQ55652019-870B76B9-7015-470D-8A9B-3FA3C9F11B69
P2860
Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Predicting disease progression ...... dels and molecular biomarkers.
@en
Predicting disease progression ...... dels and molecular biomarkers.
@nl
type
label
Predicting disease progression ...... dels and molecular biomarkers.
@en
Predicting disease progression ...... dels and molecular biomarkers.
@nl
prefLabel
Predicting disease progression ...... dels and molecular biomarkers.
@en
Predicting disease progression ...... dels and molecular biomarkers.
@nl
P2093
P2860
P356
P1433
P1476
Predicting disease progression ...... dels and molecular biomarkers.
@en
P2093
Bradley C Leibovich
Christine M Lohse
Eugene D Kwon
Paul L Crispen
Stephen A Boorjian
P2860
P304
P356
10.1002/CNCR.23566
P407
P577
2008-08-01T00:00:00Z